Calcarea Carbonica
Product Images NDC 15631-0547

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Calcarea Carbonica (NDC 15631-0547). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image Description (15631 0547)

Image Description (15631 0547)
This is a description of a medication which contains active and inactive ingredients. It is used for treating a condition called newborn impetigo. The medication should be administered orally, four or six tablets taken three times daily or as per the physician's directions. Its dosage is halved for children. This medicine should be taken for self-limiting conditions, and if the symptoms don't improve in four days or worsen, the medication should be discontinued. Seeking help from a health professional might be essential in such cases. It is advised to seek professional advice before taking this medication if pregnant or nursing. This medicine should be kept away from the reach of children in a cool and dark place, and the cap should be tightly closed after use. If the capsule is broken or missing, it should not be used. The Manufacturer Rxhomeo Private Limited manufactures this medicine, and it is distributed in the US by Rxhomeo, Inc. The package contains 100 tablets inside with a VINOA¥E 8981 code. However, the last string contains various symbols, which are not readable.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.